MUMBAI, India, April 10 -- Intellectual Property India has published a patent application (202411072889 A) filed by Translational Health Science And Technology Institute, Faridabad, Haryana, on Sept. 29, 2024, for 'an engineered polypeptide complex for generating protective immune responses against monkey pox (mpox).'
Inventor(s) include Samal, Sweety; Ahmed, Shubbir; and Awasthi, Amit.
The application for the patent was published on April 10, under issue no. 15/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to the development of an engineered polypeptide complex, aimed at inducing protective antibody responses against the Monkey pox virus. The polypeptide complex is structured with antigenic domains connected via specific linkers to a nanocage vehicle. When expressed in a suitable bacterial expression system, the complex generates a recombinant soluble protein that, upon administration in vivo, elicits an immune response that provides protection against Mpox virus infection. The invention also covers the method for producing this engineered polypeptide complex, as well as a vaccine formulation comprising the complex along with pharmaceutically acceptable excipients."
Disclaimer: Curated by HT Syndication.
